Can an app save kidneys and the planet? new study investigates
NCT ID NCT07613593
First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times
Summary
This study will look at how people with chronic kidney disease use a digital app called MyRenalCare. Researchers want to see if the app helps improve health, lowers hospital visits, and reduces costs and environmental impact. About 1,000 adults under kidney care will be included.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2026
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
* Retrospective: \~450-500 existing users + matched controls(24 months data). * Comparison with entire WKC CKD population * Prospective: \~500-550 new users + matched controls (6 months). * Exploratory: \~500 dialysis or pre transplant MyRenalCare users (no matched controls). * Qualitative: 15-25 patients + 10-15 staff.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 5.1.1 Inclusion criteria - MyRenalCare users (retrospective and prospective cohorts) Adults will be eligible for inclusion in the MyRenalCare cohorts if they meet all of the following: 1. Aged 18 years or over. 2. Under the care of the Wessex Kidney Centre 3. Registered with, or offered and subsequently enrolled onto, the MyRenalCare platform during the defined retrospective or prospective periods. 4. Able to understand study information and, where applicable, provide informed consent for use of their data for research purposes. Specific CKD stage definitions and thresholds (e.g. based on eGFR, albuminuria or uPCR) will be documented in the study manual to ensure consistent application. 5.1.2 Inclusion criteria - matched usual care controls Adults will be eligible for inclusion in the matched control cohorts if they meet all of the following: 1. Aged 18 years or over. 2. Under the care of the Wessex Kidney Centre for chronic kidney disease. 3. Not registered with or using MyRenalCare at any point during the relevant observation period. 4. Have sufficient clinical and administrative data available in the renal electronic patient record to enable matching and outcome assessment. Controls will be identified retrospectively from the renal electronic patient record and matched to MyRenalCare users using a predefined matching strategy. 5.1.3 Inclusion criteria - qualitative interview participants (patients and staff) Patients will be eligible to take part in the qualitative interview component if they meet all of the following: 1. Aged 18 years or over. 2. Currently using, or recently offered, the MyRenalCare platform as part of their CKD care at the Wessex Kidney Centre. 3. Able to understand spoken and written English to the extent required for participation in an interview. 4. Able and willing to provide written informed consent for participation in a recorded interview. 5. Belong to a demographic or clinical subgroup of interest for the study (e.g. varying age, ethnicity, CKD stage, or digital engagement level), as part of purposive sampling to support diversity and equity analysis. Clinical staff will be eligible if they meet all of the following: 1. Employed by PHU or working in direct partnership with the Wessex Kidney Centre. 2. Directly involved in the care of patients with chronic kidney disease and/or in the implementation or support of MyRenalCare. 3. Able and willing to provide informed consent for a recorded interview. 4. Able to reflect on experiences and observations relevant to the delivery, uptake, or equity implications of digital health in CKD. Exclusion Criteria: 1. Patients with acute kidney injury without established chronic kidney disease. 2. Patients with a very limited life expectancy where participation in routine digital monitoring is not appropriate, as judged by the clinical team. 3. Patients who have previously indicated that they do not wish their routinely collected clinical data to be used for research where such opt-out applies to this study. 4. Patients who are unable to be identified reliably in the available data sources (for example, inconsistent or missing key identifiers). 5. Any other situation where, in the opinion of the responsible clinician, participation in the study processes (including data use) would be inappropriate or unduly burdensome. 6. Clinical staff who are not directly involved in the care of patients with chronic kidney disease or in the implementation of the MyRenalCare platform. 7. Staff members currently on extended leave or unable to participate during the data collection period. 8. Individuals who do not wish to have their views included in recorded interview transcripts or are unable to provide informed consent for participation. 9. Any situation where, in the opinion of the study team or the individual's manager, participation would be inappropriate or burdensome due to role, availability, or conflict of interest.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic kidney disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Portsmouth Hospitals University NHS Trust
RECRUITINGPortsmouth, Hampshire, PO6 3LY, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a breathing workout and walks help dialysis patients with irregular heartbeats?
- Can AI-Tailored heat warnings shield chronic disease patients from dangerous temperatures?
- Can a Patient's own kidney cells hold off dialysis?
- A blood test at 50 could flag your risk of five diseases. can an app stop them?
- Two drugs, one goal: can finerenone or semaglutide cut kidney damage markers?
- One team, three conditions: can coordinated care tame heart, kidney, and diabetes?